World's Best Scientists 2026 revealed!
Michael J. A. Tanner

Michael J. A. Tanner

Overview

Michael J. A. Tanner is affiliated with the University of Bristol in the United Kingdom. Their research predominantly spans the field of medicine with a focus on oncology, pulmonary and respiratory medicine, endocrinology, diabetes and metabolism, cancer research, and cardiology and cardiovascular medicine.

The scientist's work covers a variety of topics related to cancer treatment and research including breast cancer treatment studies, cancer treatment and pharmacology, prostate cancer treatment and research, radiopharmaceutical chemistry and applications, cancer immunotherapy and biomarkers, CAR-T cell therapy research, and lung cancer treatments and mutations.

Frequent coauthors collaborating with Michael J. A. Tanner include Karim Fizazi, Alice Bernard-Tessier, Chris Garratt, Tarja Ikonen, and Pasi Pohjanjousi.

Michael J. A. Tanner has published extensively in several academic venues. The most frequent publication outlets include:

  • Annals of Internal Medicine (12 publications)
  • Journal of Clinical Oncology (2 publications)
  • Obstetrical & Gynecological Survey (1 publication)
  • NEJM Evidence (1 publication)
  • Cancer Immunology Immunotherapy (1 publication)

Recent papers authored by or involving Michael J. A. Tanner include:

  • Widespread Implementation of a Low-Cost Telehealth Service in the Delivery of Antenatal Care During the COVID-19 Pandemic: An Interrupted Time-Series Analysis, 2022, Obstetrical & Gynecological Survey
  • Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer, 2023, NEJM Evidence
  • First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma, 2021, Cancer Immunology Immunotherapy
  • Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis, 2021, Breast Cancer Research and Treatment
  • Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181), 2020, Clinical and Translational Science

Best Publications

  • Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene

    L. J. Bruce;D. L. Cope;G. K. Jones;A. E. Schofield

  • A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane

    Lesley J Bruce;Roland Beckmann;M Leticia Ribeiro;Luanne L Peters

  • The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence.

    M J A Tanner;P G Martin;S High

  • cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression.

    N D Avent;K Ridgwell;M J A Tanner;D J Anstee

  • Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis

    F. E. Karet;F. J. Gainza;A. Z. Györy;R. J. Unwin

  • The structure and function of band 3 (AE1): Recent developments (Review)

    Michael J. A. Tanner

  • The expression of human blood group antigens during erythropoiesis in a cell culture system.

    Mark J.G. Southcott;Michael J.A. Tanner;David J. Anstee

  • Defective anion transport activity of the abnormal band 3 in hereditary ovalocytic red blood cells.

    Ann E. Schofield;David M. Reardon;Michael J. A. Tanner

  • Use of a novel rapid preparation of fat-cell plasma membranes employing Percoll to investigate the effects of insulin and adrenaline on membrane protein phosphorylation within intact fat-cells.

    Graham Belsham;Richard M. Denton;Michael J. A. Tanner

  • Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells.

    Lesley J. Bruce;Oliver Wrong;Ashley M. Toye;Mark T. Young

  • Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3

    W J Mawby;C H Holmes;D J Anstee;F A Spring

  • Separation and some properties of the major proteins of the human erythrocyte membrane

    M. J. A. Tanner;D. H. Boxer

  • The Expression of Human Blood Group Antigens During Erythropoiesis in a Cell Culture System: Presented in part as an abstract at the 39th American Society of Hematology Meeting, December 5-9, 1997 (Blood 90:175b, 1997 [abstr, suppl 1, part 2]).

    Mark J.G. Southcott;Michael J.A. Tanner;David J. Anstee

  • Erythrocyte detergent-resistant membrane proteins: Their characterization and selective uptake during malarial infection

    Sean C. Murphy;Benjamin U. Samuel;Travis Harrison;Kaye D. Speicher

  • Human BTR1, a new bicarbonate transporter superfamily member and human AE4 from kidney.

    Mark D. Parker;Elizabeth P. Ourmozdi;Michael J.A. Tanner

  • Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions.

    Lesley J. Bruce;Susan M. Ring;David J. Anstee;Marion E. Reid

  • The membrane change in En(a-) human erythrocytes. Absence of the major erythrocyte sialoglycoprotein.

    M J A Tanner;D J Anstee

  • Identification and partial characterization of the human erythrocyte membrane component(s) that express the antigens of the LW blood-group system

    G Mallinson;P G Martin;D J Anstee;M J A Tanner

  • Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.

    C H Holmes;K L Simpson;S D Wainwright;C G Tate

  • Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex

    Lesley J. Bruce;Sandip Ghosh;May Jean King;D. Mark Layton

Frequent Co-Authors

David J. Anstee
David J. Anstee University of Bristol
Susan M. Ring
Susan M. Ring University of Bristol
Narla Mohandas
Narla Mohandas New York Blood Center
Stephen High
Stephen High University of Manchester
Christopher G. Tate
Christopher G. Tate MRC Laboratory of Molecular Biology
Marion E. Reid
Marion E. Reid New York Blood Center
Luanne L. Peters
Luanne L. Peters The Jackson Laboratory
Philip S. Low
Philip S. Low Purdue University West Lafayette
Ben Roelofsen
Ben Roelofsen Utrecht University
Geoff Daniels
Geoff Daniels NHS Blood and Transplant

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA can open doors to diverse careers beyond traditional lab roles. One growing field is health information management and medical coding, both of which are accessible through online learning. Understanding the differences between medical coding certification options, such as CPC vs. CCS, is important for graduates considering non-clinical healthcare jobs.

For those interested in job prospects and earning potential, it helps to know how much does a medical coder make. This role offers competitive salaries and flexibility, making it appealing to science graduates with analytical skills.

The medical billing and coding job outlook remains strong due to the increasing need for accurate digital health records. Many pursue this pathway by enrolling in a him degree program, often available online and suitable for students with a background in life sciences.

Exploring these options can expand career possibilities for Biology and Biochemistry graduates seeking flexible and in-demand roles in healthcare.

Best Scientists Citing Michael J. A. Tanner

Recently Published Articles